Recent trends in orexin research-2010 to 2015

被引：72

作者：

Boss, Christoph ^{[1
]}

Roch, Catherine ^{[2
]}

机构：

[1] Actel Pharmaceut Ltd, Drug Discovery Chem, CH-4123 Allschwil, Switzerland

[2] Actel Pharmaceut Ltd, Drug Discovery Pharmacol, CH-4123 Allschwil, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 15期

关键词：

Orexin; G-protein-coupled receptors; Sleep disorders; Anxiety; Addiction; Hypothalamus; RECEPTOR ANTAGONIST 2-SORA; SLEEP; DISCOVERY; POTENT; TETRAHYDROISOQUINOLINES; HYPOTHALAMUS; HYPOCRETINS; ACT-462206; EXPRESSION; NARCOLEPSY;

D O I：

10.1016/j.bmcl.2015.05.012

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Specific neurons in the lateral hypothalamus produce the orexin neuropeptides (orexin-A and orexin-B). The orexin-peptides are transported to areas of the brain regulating sleep-wake cycles, controlling food intake or modulating emotional states such as panic or anxiety. The orexin system, consisting of the two orexin-neuropeptides and two G-protein-coupled receptors (the orexin-1 and the orexin-2 receptor) is as well involved in reward and addictive behaviors. The review reflects on the most recent activities in the field of orexin research. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：2875 / 2887

页数：13

共 81 条

[1] Aissaoui H., 2010, WO Patent, Patent No. [WO2010/044054 A1, 2010044054, 2010044054A1]
[2] Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction
Aston-Jones, Gary
Smith, Rachel J.
Sartor, Gregory C.
Moorman, David E.
Massi, Lema
Tahsili-Fahadan, Pouya
Richardson, Kimberlei A.
[J]. BRAIN RESEARCH, 2010, 1314 : 74 - 90
[3] Betschart C., 2011, WO Patent, Patent No. [2011073316A1, 2011073316, WO 2011/073316 A1]
[4] Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Betschart, Claudia
Hintermann, Samuel
Behnke, Dirk
Cotesta, Simona
Fendt, Markus
Gee, Christine E.
Jacobson, Laura H.
Laue, Grit
Ofner, Silvio
Chaudhari, Vinod
Badiger, Sangamesh
Pandit, Chetan
Wagner, Juergen
Hoyer, Daniel
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7590 - 7607
[5] The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia
Bettica, Paolo
Squassante, Lisa
Zamuner, Stefano
Nucci, Gianluca
Danker-Hopfe, Heidi
Ratti, Emiliangelo
[J]. SLEEP, 2012, 35 (08) : 1097 - 1104
[6] Bolli M., 2014, [No title captured], Patent No. [WO2014/141065, 2014141065]
[7] A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects
Bonaventure, Pascal
Yun, Sujin
Johnson, Philip L.
Shekhar, Anantha
Fitz, Stephanie D.
Shireman, Brock T.
Lebold, Terry P.
Nepomuceno, Diane
Lord, Brian
Wennerholm, Michelle
Shelton, Jonathan
Carruthers, Nicholas
Lovenberg, Timothy
Dugovic, Christine
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 352 (03) : 590 - 601
[8] Orexin receptor antagonists - a patent review (2010 to August 2014)
Boss, Christoph
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (12) : 1367 - 1381
[9] Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
Boss, Christoph
Roch-Brisbare, Catherine
Steiner, Michel A.
Treiber, Alexander
Dietrich, Hendrik
Jenck, Francois
von Raumer, Markus
Sifferlen, Thierry
Brotschi, Christine
Heidmann, Bibia
Williams, Jodi T.
Aissaoui, Hamed
Siegrist, Romain
Gatfield, John
[J]. CHEMMEDCHEM, 2014, 9 (11) : 2486 - 2496
[10] Orexin Receptor Antagonism: A New Principle in Neuroscience
Boss, Christoph
Brisbare-Roch, Catherine
Jenck, Francois
Aissaoui, Hamed
Koberstein, Ralf
Sifferlen, Thierry
Weller, Thomas
[J]. CHIMIA, 2008, 62 (12) : 974 - 979

← 1 2 3 4 5 6 7 8 9 →